Business · 11/02/2003
FDA Releases Revised Guidance on Impurities in New Drug Substances
The FDA has made available a revised guidance on impurities in new drug substances, clarifying and updating previous guidance, and aligning with more recent ICH guidelines, to help applicants register their drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →